Edition:
United States

Cardinal Health Inc (CAH)

CAH on New York Consolidated

71.11USD
8 Dec 2016
Change (% chg)

$0.61 (+0.87%)
Prev Close
$70.50
Open
$70.57
Day's High
$71.37
Day's Low
$70.06
Volume
2,362,331
Avg. Vol
2,737,593
52-wk High
$91.22
52-wk Low
$62.70

CAH

Chart for CAH

About

Cardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear... (more)

Overall

Beta: 0.71
Market Cap(Mil.): $22,564.46
Shares Outstanding(Mil.): 320.06
Dividend: 0.45
Yield (%): 2.55

Financials

  CAH Industry Sector
P/E (TTM): 17.10 19.12 40.19
EPS (TTM): 4.12 -- --
ROI: 9.84 11.50 59.53
ROE: 20.79 13.06 67.27

BRIEF-Navidea Biopharmaceuticals enters asset purchase agreement with Cardinal Health

* Press release - Navidea signs asset purchase agreement with Cardinal Health

Nov 23 2016

Valeant heralds second act of pricing pushback

NEW YORK (Reuters Breakingviews) - A disastrous quarter for Valeant Pharmaceuticals represents a bad sign of things to come for a whole industry. The embattled company again slashed its profit forecast, this time to below the lower end of a previous range. Some problems are specific to Valeant. Intensifying pressure stands to upend business models heavily dependent on raising prices.

Nov 08 2016

BRIEF-Cardinal Health sees FY 2017 non-gaap EPS $5.40 to $5.60 from cont ops

* Fy2017 earnings per share view $5.59, revenue view $130.84 billion -- Thomson Reuters I/B/E/S

Oct 31 2016

BRIEF-Cardinal Health Q4 non-gaap earnings per share $1.14

* Cardinal Health reports Q4 and fiscal 2016 results, provides fiscal 2017 outlook

Aug 02 2016

BRIEF-Cardinal Health enters into amended and restated 5-yr credit agreement

* On June 16, 2016, co entered into an amended and restated five-year credit agreement - SEC Filing

Jun 21 2016

BRIEF-Cardinal Health to prepare NETSPOT doses for Advanced Accelerator Applications

* Advanced Accelerator Applications S.A. says selected Cardinal Health to supply Gallium 68 dotatate doses to u.s. Hospitals and imaging centers Source text for Eikon: Further company coverage: )

Jun 09 2016

Competitors

Earnings vs. Estimates